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Context: Exposure to maternal adiposity during pregnancy is associated with higher offspring birth
weight and greater adiposity through childhood and adult life. As birth weight reflects the
summation of lean and fat mass, the extent to which fat mass at birth tracks into later life is
unknown.
Objective: To determine whether fat mass at birth is associated with child and adolescent adiposity.
Design, Setting, and Participants: UK birth cohort with markers of neonatal fat mass; cord blood
leptin, adiponectin, and birth weight and adiposity outcomes at age 9 (n = 2775) and 17 years
(n = 2138).
Main Outcomes: Offspring body mass index (BMI), waist circumference, dual-energy X-ray
absorptiometry–determined fat mass, and obesity at age 9 and 17 years.
Results:Higher cord blood leptin was associatedwith higher z scores of fatmass [difference inmean
per 10 pg/mL: 0.03 standard deviation (SD); 95% confidence interval (CI), 0.00 to 0.06], waist
circumference (0.04 SD; 95% CI, 0.00 to 0.07), and BMI (0.04 SD; 95% CI, 0.00 to 0.08) at age 9.
However, by age 17 the adjusted results were attenuated to the null. Cord blood adiponectin was
not associatedwithmeasures of adiposity at age 9. At age 17, cord blood adiponectin was positively
associated with fat mass (0.02 SD per 10 mg/mL; 95% CI, 0.02 to 0.03) and waist circumference (0.04
SD per 10 mg/mL; 95% CI, 0.03 to 0.05). Birth weight was positively associated with waist
circumference (0.03 SD per 100 g; 95% CI, 0.02 to 0.04) and BMI (0.02 SD per 100 g; 95% CI,
0.00 to 0.03), but not fat mass or odds of obesity. Cord blood leptin and adiponectin were not
associated with obesity at either age.
Conclusions: Increased cord blood leptin and adiponectin, known surrogates of fetal fat mass, were
weakly associated with increased fat mass in late childhood and adolescence, respectively. (J Clin
Endocrinol Metab 102: 499–506, 2017)
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Exposure to maternal adiposity during pregnancy isassociated with higher offspring birth weight and
greater adiposity through childhood and adult life (1).
Developmental overnutrition has been proposed as a
mechanism by which excessive transplacental passage of
nutrients facilitates the development of larger babies with
greater fat mass. Evidence from within-sibling studies,
comparisons of maternal and paternal exposures, and the
use of genetic variants as proxies for the maternal ex-
posures support maternal adiposity and developmental
overnutrition causing greater adiposity in offspring at
birth (2–4). However, whether this causal effect extends
to long-term offspring adiposity is unclear. A longer term
effect may occur as a result of tracking of birth fatness
across the life course. However, because birth weight is
unable to distinguish relative contributions of lean vs fat
mass (5, 6), few studies to date have been able to de-
termine the extent to which greater fat mass at birth
tracks into later life.
Umbilical cord blood leptin is widely recognized as an
accurate biomarker for neonatal fat mass (7). Maternal
exposures, including maternal adiposity, which may
cause developmental overnutrition, have been associated
with increased cord leptin and neonatal adiposity at birth
(8, 9). In animal models, fetal leptin has also been pro-
posed to contribute the long-term programming of hy-
pothalamic feeding circuits, thereby providing ameans by
which leptin can influence long-term adiposity inde-
pendent of tracking of adiposity from birth (10). How-
ever, use of cord blood leptin in determining whether
neonatal fat mass tracks across childhood has been
limited (11–14). This primarily reflects the scarcity of
large prospective birth cohorts with cord blood samples
and detailed measures of offspring adiposity as well as
potential confounders. Studies that have made some
assessment of this to date have had relatively small sample
sizes (N = 56 to 588) (11–14), andwe are not aware of any
study having followed children beyond age 7 years. These
studies have reported inconsistent results, with higher cord
leptin associated with both a lower (11) and higher (12)
bodymass index (BMI) at age 3 years, and a higher BMI
at age 7 years (14).
Neonatal levels of adiponectin, which has insulin-
sensitizing effects in adults, are approximately 4 to 7
times higher than maternal levels. Furthermore, whereas
maternal circulating concentrations of adiponectin are
inversely associatedwith BMI, higher levels of cord blood
adiponectin are associated with higher birth weight (11,
15). That higher cord blood adiponectin concentrations
might reflect increased fat mass in neonates is suggested
by mouse studies where overexpression of fetal adipo-
nectin was positively related to the size of fat depots in
early life, whereas adiponectin knockout fetuses display
lower body weight and lower fat content (16). Given this
effect of adiponectin on body composition, specifically its
fat deposition–enhancing effect in mice, and the known
relationships of leptin in humans to fat mass, we hy-
pothesized that both cord blood leptin and adiponectin
would be positively associated with offspring adiposity in
prepubertal children and adolescents.
The aim of this study was to determine whether cord
blood leptin and adiponectin were positively associated
with later obesity, BMI, waist circumference, and fat
mass and whether this is independent of maternal BMI.
For comparison, we also examined associations of birth
weight with these outcomes.
Research Design and Methods
Study population
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective birth cohort study investigating the
health and development of children (17, 18). The studyWeb site
contains details of all of the data that are available through a
fully searchable data dictionary (http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary/). Ethical approval was
obtained from the ALSPAC Law and Ethics Committee and the
National Health Service local ethics committees. A total of
14,541 women were initially enrolled, with 5011 mother/
offspring pairs having a suitable cord blood sample. A de-
tailed outline of the exclusion criteria for the analysis reported in
this study and numbers with missing data are shown in Fig. 1.
We included participants when they had (1) attended and
completed assessments at either the 9- or 11-year clinic as-
sessment, or (2) attended the 15- or 17-year clinic assessment.
The eligible cohort for the current analysis was 2775 mother/
offspring pairs at age 9 to 11 years and 2138 mother/offspring
pairs at age 15 to 17 years.
Cord blood assays
Cord blood samples were collected at the time of delivery,
initially stored at 4°C for 0 to 8 days before plasma was sep-
arated and then stored at 220°C before being transferred to
long-term storage at280°C. Cord blood leptin and adiponectin
were measured using commercially available enzyme-linked
immunosorbent assay kits [Quantikine human leptin immu-
noassay (catalog no. PDLP00), Quantikine human total
adiponectin/Acrp30 (catalog no. PDRP300), both R&D Sys-
tems, Minneapolis, MN]. Analysis of the cord blood was
completed within a maximum of 3 freeze-thaw cycles and
remained at 280°C in between thaws. The interassay co-
efficients of variability were 9.5% for leptin and 3.2% for
adiponectin.
Obstetric/perinatal data
Six trained research midwives retrospectively extracted data
from obstetric medical records, and error rates were consis-
tently,1%.These data includedweight at every antenatal clinic
visit (used to determine gestational weight gain), complications
during pregnancy (hypertensive or diabetic disorders), and
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mode of delivery. Gestational age and sex and birth weight of
offspring were obtained from hospital records at the time of
birth. Maternal age, prepregnancy height and weight, smoking
status (defined as never smoked, smoked before but not during
pregnancy, and smoked during pregnancy), parity, occupa-
tional social class, and highest educational attainment were
obtained from questionnaires completed by the mothers in early
and advanced stages of pregnancy. Occupation was used to
allocate social class groups using the 1991 British Office of
Population and Census Statistics classification.
Offspring childhood and adolescent adiposity
measurements
Identical protocols were used at all follow-up clinics. At each
clinic assessment, participants’ age in months was recorded and
their weight and height were measured in light clothing and
without shoes. Weight was measured to the nearest 0.1 kg using
Tanita scales. Height wasmeasured to the nearest 0.1 cmusing a
Harpenden stadiometer. Dual-energy X-ray absorptiometry
scans were used to measure total fat mass. Waist circumference
was measured to the nearest 1 mm at the midpoint between the
lower ribs and the pelvic bone with a flexible tape and with the
child breathing normally. Offspring obesity was classified
using BMI and criteria defined by the In-
ternational Obesity Task Force (19).
Statistical analysis
The relationship between exposures
(birth weight and cord blood adipokines)
and outcomes (BMI, waist circumference,
and fat mass at ages 9 to 11 years and 15
to 17 years) was examined by Spearman
correlation. Linear (offspring BMI, waist
circumference, and fat mass) and logistic
(offspring obesity) regression models were
used to examine the associations between
birth weight and cord blood measures and
offspring BMI, waist circumference, fat
mass, and obesity at age 9 and 17 years.
Offspring waist circumference and fat mass
were log transformed to produce approxi-
mately normal distributions of regression
model residuals. Within-cohort logged fat
mass and waist circumference z scores
(participant value minus mean for the sex
and age category 4 standard deviation for
the sex and age category) were created using
1 year age categories. BMI z scores were
created using the UK 1990 British growth
reference (20). Birth weight was adjusted for
sex, gestational age, and number of off-
spring (singletons or twins) using nonlinear
regression fitting a Gompertz curve.
Three incremental analyses were per-
formed to adjust for potential confounders
(Supplemental Fig. 1). The basic model
(model 1) adjusted for offspring sex and age
at outcome measurement alone (and off-
spring height when fat mass is the out-
come). In model 2 we additionally adjusted
for maternal confounders (age, smoking,
parity, occupational social class, education, and prepregnancy
BMI). In the fully adjusted model (model 3) we additionally
adjusted for pregnancy characteristics (gestational age at birth,
mode of delivery, gestational weight gain, hypertensive and
diabetic disorders of pregnancy). In these analyses, because we
have scaled the exposures (birth weight, cord blood leptin, and
adiponectin) and outcomes (BMI, waist circumference, and fat
mass) on their standard deviations, the resultant differences in
means from the multivariable linear regression models are
equivalent to partial (adjusted) correlation coefficients and can
be interpreted in this way.
There were small amounts of missing data on some covari-
ables included in the multivariable models (Fig. 1). Twenty im-
putation data setswere generated by chained equations (21),with
all cord exposures, birth weight, the covariates specified for
model 3, and the measurements from the 11-year clinic and 15-
year clinic informing imputation of missing values in the 9-year
clinic and 17-year clinic, respectively (hereafter referred to as 9
and 17 year). The distributions of observed and imputed vari-
ables were similar (Supplemental Table 1). In the following
sections, we present results from the imputed datasets and, for
comparison, present results from those with complete con-
founders (N = 1041 to 1776) in Supplemental Material (Sup-
plemental Tables 5–8).
Figure 1. ALSPAC participant flowchart.
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All statistical analyses were performed using Stata (version
13.0) software (StataCorp, College Station, TX).
Results
Table 1 summarizes the maternal and offspring charac-
teristics for those participants with cord blood measures
who completed at least 1 clinic assessment, with Sup-
plemental Table 1 demonstrating the similarity of the
observed and imputed data. Supplemental Table 2 shows
the Spearman correlation between exposures (birth
weight and cordblood adipokines) andoutcomes (markers
of anthropometry at age 9 and 17 years). Birth weight was
positively correlated with cord blood leptin (n = 4751, r =
0.33) and, to a lesser degree, with cord blood adiponectin
(n = 4707, r = 0.14). Cord leptin and adiponectin were
positively correlated (n = 4962, r = 0.11). Birth weight and
leptin also positively correlated with fat mass, BMI, and
waist circumference at age 9 and 17 years. There was a
weak inverse association between cord adiponectin and
waist circumference and BMI at age 9. Among those
participants with assessments at both clinics (at age 9 and
17 years), measurements at each clinic were highly cor-
related (0.74 for BMI, 0.74 for fat mass, and 0.66 for waist
circumference).
Table 2 shows the multivariable associations between
cord blood leptin, adiponectin, and birth weight and z
scores of offspring fat mass, waist circumference, BMI,
and obesity at age 9 years. Cord blood leptin was posi-
tively associated with fat mass, waist circumference, and
BMI at age 9 (model 1). The effect size was largely at-
tenuated with adjustment for maternal and pregnancy
characteristics (Table 2), with the individual univariate
association of maternal and pregnancy characteristics
on cord leptin, cord adiponectin, and birth weight
shown in Supplemental Table 3. A similar but weaker
pattern was observed for measures at age 17 where
cord leptin was associated with z scores of fat mass,
waist circumference, and BMI and with the risk of
obesity (Table 3). These associations were similarly
attenuated to the null after adjustment for potential
confounders.
Cord blood adiponectin was not associated with any
measures of adiposity at age 9 years (Table 2). At age 17
years, cord blood adiponectin was positively associated
with fat mass andwaist circumference, with the effect size
strengthened after adjustment for maternal and preg-
nancy characteristics (Table 3).
Birth weight was positively associated with fat mass,
waist circumference, and BMI at age 9 years and 17 years
and showed a weak relationship with obesity in both age
groups (Tables 2 and 3). After adjustment for maternal
and pregnancy characteristics, increasing birth weight
Table 1. Maternal and Offspring Characteristics
Attended at Least 1 Clinic
Assessment (n = 2955)
N Observations
(%)
Median
(IQR)
Maternal characteristics
Age 2914 29 (26, 32)
Smoking
Never 2103 (73.8)
Before, not during
pregnancy
212 (7.4)
During pregnancy 533 (18.7)
BMI 2587 22.2 (20.5, 24.4)
Parity
0 1274 (45.5)
1 1011 (36.1)
2 383 (13.7)
3 101 (3.6)
4+ 30 (1.1)
Education
Left school at 16 1713 (61.3)
A level 689 (24.8)
Degree 391 (14.0)
Social class
I (least
disadvantaged)
140 (5.9)
II 807 (33.7)
IIIa 1038 (43.5)
IIIb 162 (6.8)
IV 203 (8.5)
V (most
disadvantaged)
40 (1.7)
Pregnancy characteristics
Gestational age at
birth, wk
2914 40 (39, 41)
Model of delivery
Spontaneous 2253 (77.9)
Breech 36 (1.3)
Cesarean section 249 (8.6)
Forceps 167 (5.8)
Vacuum 154 (5.3)
Other 32 (1.1)
Gestational weight
gain, kg
2668 12.5 (9.5, 15.2)
Hypertension and
pre-eclampsia
No hypertensive
disorders
2449 (84.5)
Hypertension, no
pre-eclampsia
420 (13.9)
Hypertension and
pre-eclampsia
49 (1.7)
Diabetes
No glycosuria or
diabetes
2651 (95.8)
Existing diabetes 10 (0.4)
Gestational diabetes 16 (0.6)
Glycosuria 91 (3.3)
Offspring characteristics
Sex
Male 1414 (47.9)
Female 1541 (52.2)
Birth weight, kg 2891 3.5 (3.1, 3.8)
Cord leptin, pg/mL 2952 6.4 (3.6, 12.1)
Cordadiponectin,mg/mL 2927 75.7 (53.6, 98.4)
(Continued )
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remained associated with greater waist circumference
and BMI, with the association with fat mass and obesity
attenuated to the null.
Results did not differ substantially when absolute
measures of adiposity at age9 years (SupplementalTable 4)
or age 17 years were considered (Supplemental Table 5).
Results were similar for nonimputed analyses but with
wider confidence intervals (Supplemental Tables 6–9).
Discussion
In this prospective birth cohort study, cord leptin, a
marker of neonatal fat mass, exhibited relatively weak
relationshipswith latermeasures of adiposity. Thesewere
largely attenuated by adjustment for maternal factors,
particularly in later childhood. In contrast, adiponectin
exhibited no relationshipwithmeasures of fat mass at age
9 years and showed aweak relationshipwith fat mass and
waist circumference at age 15 years. Neither cord leptin
nor adiponectin was associated with the risk of being
classed as obese in late childhood or adolescence. Taken
together, this would suggest that neonatal fat mass per se
has a limited contribution in determining fat mass in
adolescence.
To date, birth weight, as a proxy for intrauterine
growth, and its relationship to adult BMI have been
extensively studied. Similar to our findings, studies
principally demonstrate a positive association between
birth weight and childhood and adult fat mass, BMI, and
waist circumference (22). To try to examinewhether birth
weight is simply acting as a surrogate for neonatal fat
mass, we previously used the Ponderal index (birth
weight/length3), a measure of fatness, and demonstrated
positive associations with lean body mass, total body fat,
and the fat-to-lean mass ratio at age 9 years (23). Al-
though this suggests that neonatal fat mass is related to
later adiposity, the Ponderal index is a relatively poor
measure of neonatal total body fat (24).
To extend and improve on this work, the present study
used cord blood leptin, a strong correlate of neonatal fat
Table 1. Continued
Attended at Least 1 Clinic
Assessment (n = 2955)
N Observations
(%)
Median
(IQR)
Height, cm Age 9: 2561 140 (136, 144)
Age 11: 2363 151 (146, 156)
Age 15: 1816 169 (163, 175)
Age 17: 1648 170(164, 178)
Fat mass, kg Age 9: 2460 7.3 (4.9, 11.2)
Age 11: 2327 10.0 (6.8, 15.7)
Age 15: 1716 13.7 (8.6, 20.6)
Age 17: 1594 16.7 (11.0, 23.5)
Waist circumference,
cm
Age 9: 2574 61.1 (57.4, 66.6)
Age 11: 2362 66.0 (61.8, 73.5)
Age 15: 1475 75.4 (71.0, 81.5)
BMI, kg/m2 Age 9: 2560 17.0 (15.7, 19.1)
Age 11: 2359 18.4(16.6, 21.0)
Age 15: 1811 20.7 (19.0, 23.1)
Age 17: 1647 22.0 (20.2, 24.7)
Obese Age 9: 102 (4.0)
Age 11:116 (4.9)
Age 15: 78 (4.3)
Age 17:105 (6.4)
Age at attendance, y Age 9: 2583 9.8 (9.6, 10.0)
Age 11: 2378 11.8 (11.6, 11.8)
Age 15: 1838 15.4 (15.3, 15.6)
Age 17: 1695 17.8 (17.6, 17.9)
Figures are numbers (%) unless stated otherwise.
Abbreviation: IQR, interquartile range.
Table 2. Associations of BirthWeight and Cord Blood Analyte With Fat Mass, Waist Circumference and BMI z
Scores, and Obesity Outcome at Age 9 Years
Exposure Outcome
Fat Mass z Scorea Waist Circumference z Score BMI z Score Obesity
Coefficient 95% CI P Coefficient 95% CI P Coefficient 95% CI P OR 95% CI P
Leptin, per
10 pg/mL
Model 1 0.07 0.04, 0.10 ,0.001 0.08 0.05, 0.12 ,0.001 0.11 0.07, 0.15 ,0.001 1.15 1.00, 1.31 0.046
Model 2 0.04 0.00, 0.07 0.023 0.05 0.01, 0.08 0.008 0.06 0.02, 0.10 0.003 1.00 0.85, 1.17 0.993
Model 3 0.03 0.00, 0.06 0.086 0.04 0.00, 0.07 0.045 0.04 0.00, 0.08 0.029 0.95 0.81, 1.12 0.548
Adiponectin,
per 10mg/mL
Model 1 0.00 20.01, 0.01 0.828 20.01 20.02, 0.00 0.072 0.00 20.02, 0.01 0.602 0.99 0.94, 1.05 0.845
Model 2 0.00 20.01, 0.01 0.916 20.01 20.02, 0.00 0.118 0.00 20.01, 0.01 0.858 1.00 0.94, 1.05 0.874
Model 3 0.00 20.01, 0.01 0.875 20.01 20.02, 0.00 0.100 0.00 20.01, 0.01 0.767 0.99 0.94, 1.05 0.834
Birth weight,
per 100 gb
Model 1 0.01 0.00, 0.02 0.006 0.03 0.03, 0.04 ,0.001 0.04 0.03, 0.05 ,0.001 1.06 1.02, 1.10 0.006
Model 2 0.00 0.00, 0.01 0.192 0.03 0.02, 0.04 ,0.001 0.04 0.03, 0.04 ,0.001 1.03 0.99, 1.07 0.193
Model 3 0.00 20.01, 0.01 0.741 0.02 0.02, 0.03 ,0.001 0.03 0.02, 0.04 ,0.001 1.01 0.96, 1.05 0.852
For this study, N= 2775. Model 1 was adjusted for offspring sex and age at measurement. Model 2 was adjusted for offspring sex, age at measurement,
andmaternal confounders (age, smoking, parity, occupational social class, education, and prepregnancy BMI).Model 3was adjusted for offspring sex, age
atmeasurement, andmaternal confounders plus pregnancy confounders (gestational age at birth,mode of delivery, gestational weight gain, hypertensive
disorders, and diabetic disorders of pregnancy).
Abbreviations: CI, confidence interval; OR, odds ratio.
aFat mass adjusted for height.
bBirth weight adjusted for sex, gestational age, and singleton/twin pregnancy.
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mass as assessed by skinfolds or total body electrical
conductivity (25), and adiponectin,which inmouse studies
is suggested to be a further positive correlate of fat mass
(16). That cord blood leptin was positively associatedwith
several adiposity measures, and specifically fat mass z
score at age 9 years, suggests that there is either accretion
of adipose tissue during intrauterine life that is maintained
throughout childhood, the propensity to develop fat mass
may be maintained, or there is a direct effect on the
programming of hypothalamic feeding circuits. However,
given our observed effect size, the contribution of neonatal
fat to later fat mass is likely to be small. For example, a
10 pg/mL increase in cord leptin would be associated
with a BMI increase from 22 to 22.1 kg/m2 at age 9 years.
In accordance with some (26–28) but not all (29, 30)
previous studies, we observed that adiponectin was
weakly positively correlated with birth weight and cord
leptin. We found some evidence for weak associations of
cord blood adiponectin with adiposity at the older age
(15–17) but none that this was mediated by increased
(and persistent) fat mass through childhood. Why
adiponectin is not related to adiposity outcomes in
earlier childhood, as leptin is, is not clear. Perhaps these
associations emerge after puberty, which has a major
impact on body composition and adipocyte number
(31). It is also possible that given the multiple tests
performed, some associations are due to chance, and
we would caution against assuming these associations
are real without further replication.
As previously shown in this cohort (32), we observed
consistent positive associations of birth weight with later
BMI and waist circumference in both early childhood
and adolescence, although null associations (coefficients
equal to 0) were found for fat mass at both ages.
Our study has several strengths, including its size,
duration of follow-up, and the availability of data on a
range of maternal, pregnancy, and social factors to
facilitate a robust analysis. This is also 1 of the very few
studies with dual-energy X-ray absorptiometry mea-
surements of body composition at different time points,
thereby overcoming the potential increase in overall mass
attributed to the expected increase in bone density that
results from increased adiposity. We do, however, ac-
knowledge some limitations. The number of children
who were overweight or obese was smaller than many
contemporary populations. That birth weight and cord
measures were not associated with the risk of being obese
may reflect this. Another limitation of the study is the loss
to follow-up. Our results may be biased if associations
were substantially different among excluded participants
due to conditioning on the variables in the model. We
acknowledge that engaged participants may exhibit
different characteristics at birth beyond gestational age
and birth weight that are representative of the whole
cohort, and also for the 2 outcomes. Replication of our
analyses in additional birth cohorts with different met-
abolic risk profiles would strengthen our findings. Cord
blood sample degradation may have contributed to
variability, but leptin and adiponectin do appear to be
stable with long-term storage (33–38). This is in stark
contrast to C-peptide, the preferred index of fetal glucose
exposure, which we were unable to measure accurately
due to degradation with long-term storage, a phenome-
non previously reported by others (39).
In conclusion, we found that cord blood leptin and
adiponectin, known surrogates of fetal fat mass, were
weakly positively associated with some measures of fat
mass in late childhood and adolescence. That these
Table 3. Associations of BirthWeight and Cord Blood AnalyteWith FatMass,Waist Circumference (at Age 15
Years), BMI z Scores, and Obesity Outcomes at Age 17 Years
Exposure Outcome
Fat Mass z Scorea Waist Circumference z Score BMI z Score Obesity
Coefficient 95% CI P Coefficient 95% CI P Coefficient 95% CI P OR 95% CI P
Leptin, per
10 pg/mL
Model 1 0.07 0.03, 0.11 ,0.001 0.06 0.02, 0.10 0.003 0.09 0.04, 0.14 ,0.001 1.13 0.99, 1.28 0.060
Model 2 0.02 20.02, 0.06 0.263 0.01 20.03, 0.05 0.545 0.03 20.02, 0.07 0.272 0.96 0.83. 1.12 0.629
Model 3 0.02 20.02, 0.05 0.444 0.01 20.03, 0.05 0.598 0.02 20.03, 0.06 0.481 0.95 0.81, 1.11 0.497
Adiponectin,
per 10mg/mL
Model 1 0.01 0.00, 0.03 0.034 0.01 0.00, 0.03 0.033 0.01 20.01, 0.02 0.245 1.03 0.98, 1.08 0.238
Model 2 0.02 0.00, 0.03 0.006 0.02 0.00, 0.03 0.008 0.01 0.00, 0.03 0.076 1.04 0.99, 1.10 0.660
Model 3 0.02 0.00, 0.03 0.007 0.02 0.00, 0.03 0.008 0.01 0.00, 0.03 0.080 1.05 0.99, 1.10 0.613
Birth weight,
per 100 gb
Model 1 0.02 0.02, 0.03 ,0.001 0.04 0.03, 0.05 ,0.001 0.04 0.03, 0.05 ,0.001 1.05 1.02, 1.09 0.004
Model 2 0.01 0.00, 0.02 0.010 0.03 0.02, 0.04 ,0.001 0.02 0.01, 0.03 ,0.001 1.02 0.98, 1.06 0.241
Model 3 0.01 0.00, 0.02 0.098 0.03 0.02, 0.04 ,0.001 0.02 0.01, 0.03 ,0.001 1.01 0.97, 1.05 0.516
For this study, N = 2138. Model 1 was adjusted for offspring sex and age at measurement. Model 2 was adjusted for offspring sex, age at measurement,
andmaternal confounders (age, smoking, parity, occupational social class, education, and prepregnancy BMI).Model 3was adjusted for offspring sex, age
atmeasurement, andmaternal confounders plus pregnancy confounders (gestational age at birth,mode of delivery, gestational weight gain, hypertensive
disorders, and diabetic disorders of pregnancy).
Abbreviations: CI, confidence interval; OR, odds ratio.
aFat mass adjusted for height.
bBirth weight adjusted for sex, gestational age, and singleton/twin pregnancy.
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associations were robust to a wide range of confounders
that may reflect intrauterine, maternal, and shared en-
vironmental exposures suggests that neonatal fat mass
may track into later life. However, we acknowledge
replication of our findings in cohorts with a different risk
profile is critical, and that the magnitude of the observed
associations is small, potentially limiting the impact that
neonatal life adiposity has on later outcomes.
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